Related Experiment Video
Updated: Apr 30, 2026

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
Published on: May 7, 2018
Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection
Takahiro Shimizu1, Hiroyuki Marusawa1, Yuko Matsumoto1
1Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Helicobacter pylori infection causes genetic mutations in the stomach lining, increasing gastric cancer risk. Activation-induced cytidine deaminase (AID) activity promotes these mutations, driving cancer development.
Area of Science:
- Gastroenterology
- Oncology
- Genetics
Background:
- Helicobacter pylori infection is a known risk factor for gastric cancer.
- Gastric cancer develops in inflamed gastric mucosa.
- Genetic aberrations accumulate in non-tumorous gastric epithelium with H. pylori infection.
Purpose of the Study:
- To investigate the genetic basis of gastric cancer in H. pylori-infected individuals.
- To identify genetic aberrations in non-tumorous gastric epithelium.
- To explore the role of inflammation in gastric carcinogenesis.
Main Methods:
- Whole-exome sequencing of gastric tumors and noncancerous tissues.
- Deep-sequencing of tumor-related genes in 34 gastritis samples.
- Deep sequencing in mouse models with TP53 and activation-induced cytidine deaminase (AICDA or AID) expression.
Main Results:
- Somatic mutations were found to accumulate in various genes within inflamed gastric tissues.
- Low-abundance mutations in TP53 (44.1%) and ARID1A (14.7%) were confirmed in gastritis tissues.
- Mutations predominantly showed C:G>T:A transitions, a marker of AID-induced cytidine deamination.
Conclusions:
- Somatic mutations accumulate in gastric mucosal tissues infected with H. pylori.
- Increased cytidine deaminase activity in these tissues promotes mutation accumulation.
- This process may contribute to gastric carcinogenesis in H. pylori-infected patients.
More Related Videos
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction

